Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL802130 | 0.98 | KDM4E (0.56) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL14822438 | 0.97 | KDM4E (0.55) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL18351605 | 0.94 | KDM4E (0.51) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL12594472 | 0.94 | KDM4E (0.55) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL15946312 | 0.94 | KDM4E (0.48) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL14822257 | 0.93 | L3MBTL1 (0.50) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL783308 | 0.93 | KDM4E (0.50) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL14822604 | 0.93 | KDM4E (0.50) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL14822261 | 0.93 | KDM4E (0.50) | KDM4EL3MBTL1ATMMAPK8PGR | |
| SCHEMBL25147207 | 0.92 | KDM4E (0.56) | KDM4EL3MBTL1ATMMAPK8PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11917903-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2024-02-27 | — | — | US | disclosed |
| US-11917903-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2024-02-27 | — | — | US | disclosed |
| US-20230320191-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| US-20230320191-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| US-11659763-B2 | Metal complexes | MERCK PATENT GMBH | 2023-05-23 | — | — | US | disclosed |
| US-11659763-B2 | Metal complexes | MERCK PATENT GMBH | 2023-05-23 | — | — | US | disclosed |
| EP-3752512-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-03-01 | — | — | EP | disclosed |
| US-11535640-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| US-11322696-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-05-03 | — | — | US | disclosed |
| US-11145828-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2021-10-12 | — | — | US | disclosed |
| US-9051233-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2015-06-09 | — | — | US | disclosed |
| US-9051233-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20120326141-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2012-12-27 | — | — | US | disclosed |
| US-20120326141-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2012-12-27 | — | — | US | disclosed |
| US-20120068170-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120068170-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
| WO-2011110262-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2011-09-15 | — | — | WO | disclosed |
| US-20110114889-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-05-19 | — | — | US | disclosed |
| US-20110114889-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-05-19 | — | — | US | disclosed |
| WO-2010136109-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2010-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145828-B2 | Metal complexes | AP1M1, AP2M1, AP3M1 | KDM4E 3877/4885L3MBTL1 3031/4885ATM 4131/4885 |
| US-20110114889-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | ETV6, EED, EML4 | KDM4E 2099/4885L3MBTL1 1997/4885ATM 3978/4885 |
| US-20230320191-A1 | METAL COMPLEXES | IMMT, MCU, SOD1 | KDM4E 4470/4885L3MBTL1 3259/4885ATM 4048/4885 |
| US-11322696-B2 | Metal complexes | AP1M1, AP3M1, AP2M1 | KDM4E 4376/4885L3MBTL1 3543/4885ATM 4372/4885 |
| US-20120068170-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SLCO2B1, SLCO1B3, SLCO4C1 | KDM4E 1899/4885L3MBTL1 3941/4885ATM 4259/4885 |
| US-11535640-B2 | Metal complexes | IMMT, MCU, SOD1 | KDM4E 4470/4885L3MBTL1 3259/4885ATM 4048/4885 |
| US-11659763-B2 | Metal complexes | IMMT, MCU, SOD1 | KDM4E 4470/4885L3MBTL1 3259/4885ATM 4048/4885 |
| US-11917903-B2 | Metal complexes | NCLN, BICRA, AP3M1 | KDM4E 3870/4885L3MBTL1 2532/4885ATM 3416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.